Umang Swami

Umang Swami, MD, MS, is Assistant Professor at the Division of Oncology – Department of Internal Medicine at Huntsman Cancer Institute, University of Utah in USA. He is a specialist in medical oncology with a focus on genitourinary cancers. He completed medical school at Sawai Man Singh Medical College in India. Thereafter, he worked as a visiting scientist at Montefiore-Einstein Cancer Center, NY, and collaborated on phase I studies of novel drugs and regimens for patients with refractory or advanced solid tumors. He completed his residency training in internal medicine at St. Barnabas Hospital, NY; a hematology-oncology fellowship from the University of Iowa; and an MS in Clinical Investigations from the College of Public Health at the University of Iowa.

Umang Swami has authored/co-authored over 100 peer-reviewed articles and book chapters and presented his research at various international conferences, including ASCO, AACR, and ASBMT. He is a reviewer and editor of multiple journals and a member of various professional societies, including ASCO, AACR, ESMO, and SITC. Umang Swami serves on the ASCO guideline panels for systemic melanoma therapy, immune-related adverse events management, and the Multi-Site Guideline Advisory Group. In addition, he is a current member of the Institutional Review Board (IRB), Radioactive Drug Research Committee (RDRC), and Human Use Subcommittee of the Radiation Safety Committee (HUS-RSC) at the University of Utah. He has mentored medical students, residents, and fellows interested in oncology research.